All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-1222-ZP414 | CCL5 (ACKR2 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CCL5-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP415 | CCL5 (CCR1 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CCL5-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP416 | CCL5 (CCR3 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CCL5-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP417 | CCL5 (CCR4 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CCL5-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-1222-ZP418 | CCL5 (CCR5 Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CCL5-CD28-CD6ζ | Lentiviral vector | T cell | ||||
XS-0323-LX353 | Anti-CCL5 VHH(X3XH353) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH353 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX354 | Anti-CCL5 VHH(X3XH354) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH354 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX355 | Anti-CCL5 VHH(X3XH355) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH355 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX356 | Anti-CCL5 VHH(X3XH356) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH356 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX357 | Anti-CCL5 VHH(X3XH357) h(CD28-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH357 | VHH-CD28-41BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX722 | Anti-CCL5 VHH(X3XH353) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH353 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX723 | Anti-CCL5 VHH(X3XH354) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH354 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX724 | Anti-CCL5 VHH(X3XH355) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH355 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX725 | Anti-CCL5 VHH(X3XH356) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH356 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX726 | Anti-CCL5 VHH(X3XH357) h(ICOS-41BB-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH357 | VHH-ICOS-4-1BB-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1091 | Anti-CCL5 VHH(X3XH353) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH353 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1092 | Anti-CCL5 VHH(X3XH354) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH354 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1093 | Anti-CCL5 VHH(X3XH355) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH355 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1094 | Anti-CCL5 VHH(X3XH356) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH356 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0323-LX1095 | Anti-CCL5 VHH(X3XH357) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 Vector | Human | X3XH357 | VHH-CD28-OX40-CD3ζ | Lentiviral vector | T cell | CAR-T | ||
XS-0823-LX7 | Anti-hCCL5 (C8) ICD(CD28-OX40-CD3ζ) CAR-MA, pAd5f35 Vector | Human | C8 | Adenoviral vectors |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION